Log In
BCIQ
Print this Print this
 

crisaborole (formerly AN2728)

  Manage Alerts
Collapse Summary General Information
Company Anacor Pharmaceuticals Inc.
DescriptionTopical borinic acid ester that inhibits phosphodiesterase-4 (PDE-4) and the production of tumor necrosis factor (TNF) alpha, IL-12 and IL-23
Molecular Target Phosphodiesterase-4 (PDE-4) ; Tumor necrosis factor (TNF) alpha
Mechanism of ActionPhosphodiesterase-4 (PDE-4) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$5,200.0M

$5,200.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/16/2016

$5,200.0M

$5,200.0M

0

Get a free BioCentury trial today